Islam; Imadul
Patent Applications and Registrations
Patent applications and USPTO patent grants for Islam; Imadul.The latest application filed is for "selective nr2b antagonists".
Company Profile
12.27.34
- Islam; Imadul - Riyadh SA
- Islam; Imadul - Richmond CA
- Islam; Imadul - Bangalore IN
- Islam; Imadul - US
- Islam; Imadul - Hercules CA
Patent Activity
| Patent | Date |
|---|---|
| Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof Grant 11,161,823 - Islam , et al. November 2, 2 | 2021-11-02 |
| Selective Nr2b Antagonists App 20210121453 - King; Dalton ; et al. | 2021-04-29 |
| Selective NR2B antagonists Grant 10,961,229 - Islam , et al. March 30, 2 | 2021-03-30 |
| Selective NR2B antagonists Grant 10,954,225 - Islam , et al. March 23, 2 | 2021-03-23 |
| Anticancer 1,3-dioxane-4,6-dione Derivatives And Method Of Combinatorial Synthesis Thereof App 20200290975 - ISLAM; Imadul ; et al. | 2020-09-17 |
| Selective Nr2b Antagonists App 20200163949 - King; Dalton ; et al. | 2020-05-28 |
| Method for treating leukemia Grant 10,639,382 - Boudjelal , et al. | 2020-05-05 |
| Selective Nr2b Antagonists App 20200115370 - Islam; Imadul ; et al. | 2020-04-16 |
| Selective Nr2b Antagonists App 20200071304 - Islam; Imadul ; et al. | 2020-03-05 |
| Selective NR2B antagonists Grant 10,501,451 - Islam , et al. Dec | 2019-12-10 |
| Selective Nr2b Antagonists App 20190314358 - King; Dalton ; et al. | 2019-10-17 |
| Selective NR2B antagonists Grant 10,344,020 - Islam , et al. July 9, 2 | 2019-07-09 |
| Selective Nr2b Antagonists App 20190117638 - King; Dalton ; et al. | 2019-04-25 |
| Selective Nr2b Antagonists App 20180312491 - Islam; Imadul ; et al. | 2018-11-01 |
| Selective Nr2b Antagonists App 20180312495 - Islam; Imadul ; et al. | 2018-11-01 |
| Selective Nr2b Antagonists App 20180250283 - King; Dalton ; et al. | 2018-09-06 |
| Selective Nr2b Antagonists App 20180110766 - King; Dalton ; et al. | 2018-04-26 |
| Selective Nr2b Antagonists App 20180000807 - King; Dalton ; et al. | 2018-01-04 |
| Selective NR2B Antagonists App 20170258777 - King; Dalton ; et al. | 2017-09-14 |
| Selective NR2B Antagonists App 20160081995 - King; Dalton ; et al. | 2016-03-24 |
| Selective NR2B antagonists Grant 9,221,796 - King , et al. December 29, 2 | 2015-12-29 |
| Selective NR2B Antagonists App 20150191452 - King; Dalton ; et al. | 2015-07-09 |
| Selective NR2B antagonists Grant 8,722,670 - King , et al. May 13, 2 | 2014-05-13 |
| Selective NR2B Antagonists App 20130085138 - King; Dalton ; et al. | 2013-04-04 |
| Plasma Carboxypeptidase B Inhibitors App 20110319366 - Buckman; Brad ; et al. | 2011-12-29 |
| Plasma carboxypeptidase B inhibitors Grant 8,008,325 - Buckman , et al. August 30, 2 | 2011-08-30 |
| Metasubstituted Thiazolidinones, Their Manufacture And Use As A Drug App 20100048891 - SCHULZE; Klause ; et al. | 2010-02-25 |
| Plasma carboxypeptidase B inhibitors Grant 7,528,173 - Buckman , et al. May 5, 2 | 2009-05-05 |
| Plasma Carboxypeptidase B Inhibitors App 20090093520 - BUCKMAN; Brad ; et al. | 2009-04-09 |
| Piperazine derivatives and their use as anti-inflammatory agents Grant 7,268,140 - Bauman , et al. September 11, 2 | 2007-09-11 |
| Platelet adenosine diphosphate receptor antagonists Grant 7,176,207 - Bryant , et al. February 13, 2 | 2007-02-13 |
| Metasubstituted thiazolidinones, their manufacture and use as a drug App 20070015759 - Schulze; Volker Klaus ; et al. | 2007-01-18 |
| Plasma carboxypeptidase b inhibitors App 20060247213 - Buckman; Brad ; et al. | 2006-11-02 |
| Indolinone derivatives and their use in treating disease-states such as cancer Grant 7,105,563 - Arnaiz , et al. September 12, 2 | 2006-09-12 |
| Platelet adenosine diphosphate receptor antagonists Grant 7,084,142 - Bryant , et al. August 1, 2 | 2006-08-01 |
| Platelet adenosine diphosphate receptor antagonists App 20060135532 - Bryant; Judi A. ; et al. | 2006-06-22 |
| Piperazine derivatives and their use as anti-inflammatory agents App 20060135487 - Bauman; John G. ; et al. | 2006-06-22 |
| Platelet adenosine diphosphate receptor antagonists App 20060122188 - Bryant; Judi ; et al. | 2006-06-08 |
| Platelet adenosine diphosphate receptor antagonists Grant 7,056,923 - Bryant , et al. June 6, 2 | 2006-06-06 |
| Platelet adenosine diphosphate receptor antagonists Grant 7,026,323 - Bryant , et al. April 11, 2 | 2006-04-11 |
| Platelet adenosine diphosphate receptor antagonists Grant 6,995,156 - Bryant , et al. February 7, 2 | 2006-02-07 |
| Piperazine derivatives and their use as anti-inflammatory agents Grant 6,977,258 - Bauman , et al. December 20, 2 | 2005-12-20 |
| Piperazine derivatives and their use as anti-inflammatory agents Grant 6,972,290 - Bauman , et al. December 6, 2 | 2005-12-06 |
| Indolinone derivatives and their use in treating disease-states such as cancer App 20050090541 - Arnaiz, Damian ; et al. | 2005-04-28 |
| Platelet adenosine diphosphate receptor antagonists App 20050065163 - Bryant, Judi A. ; et al. | 2005-03-24 |
| Platelet adenosine diphosphate receptor antagonists Grant 6,861,424 - Bryant , et al. March 1, 2 | 2005-03-01 |
| Platelet adenosine diphosphate receptor antagonists App 20050038037 - Bryant, Judi A. ; et al. | 2005-02-17 |
| Prodrugs of 1-(1-hydroxy-5-isoquinolinesulfonyl) homopiperazine App 20040266755 - Islam, Imadul ; et al. | 2004-12-30 |
| Platelet adenosine diphosphate receptor antagonists App 20040138229 - Bryant, Judi ; et al. | 2004-07-15 |
| Aryl sulfonamides and sulfamide derivatives and uses thereof Grant 6,734,182 - Islam , et al. May 11, 2 | 2004-05-11 |
| Piperazine derivatives and their use as anti-inflammatory agents App 20030158205 - Bauman, John G. ; et al. | 2003-08-21 |
| Piperazine derivatives and their use as anti-inflammatory agents App 20030139425 - Bauman, John G. ; et al. | 2003-07-24 |
| Piperazine derivatives and their use as anti-inflammatory agents Grant 6,555,537 - Bauman , et al. April 29, 2 | 2003-04-29 |
| Piperazine derivatives and their use as anti-inflammatory agents Grant 6,541,476 - Bauman , et al. April 1, 2 | 2003-04-01 |
| Platelet adenosine diphosphate receptor antagonists App 20030060474 - Bryant, Judi A. ; et al. | 2003-03-27 |
| Piperazine derivatives and their use as anti-inflammatory agents Grant 6,534,509 - Bauman , et al. March 18, 2 | 2003-03-18 |
| Aryl sulfonamides and sulfamide derivatives and uses thereof App 20030013714 - Islam, Imadul ; et al. | 2003-01-16 |
| Piperazine derivatives and their use as anti-inflammatory agents App 20020177598 - Bauman, John G. ; et al. | 2002-11-28 |
| Aryl sulfonamides and sulfamide derivatives and uses thereof Grant 6,391,877 - Islam , et al. May 21, 2 | 2002-05-21 |
| Aryl sulfonamides and sulfamide derivatives and uses thereof Grant 6,211,241 - Islam , et al. April 3, 2 | 2001-04-03 |
| Piperazine derivatives and their use as anti-inflammatory agents Grant 6,207,665 - Bauman , et al. March 27, 2 | 2001-03-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 